Downloads
Careers
Contact
Open Menu
Home
About us
Company History
Company Overview
Board Members
Our Journey
Our Brands
Leading Brands
Therapy Wise Brands
Manufacturing
Distribution
Patient Care Initiatives
Improving Health Outcomes in Hypertension
Improving Health Outcomes in Diabetes
Improving Health Outcomes in Gynaecology and Pediatrics
Improving Health Outcomes in Pain management
Improving Health Outcomes in Neurology
Investors
Details of Business
Board of Directors
Policies
Shareholding Pattern
Corporate Announcements
Financials
Annual Reports
Financial Statement of Subsidiaries
Grievances Redressal
News
M&A And Alliances
Home
About us
Company History
Company Overview
Board Members
Our Journey
Our Brands
Leading Brands
Therapy Wise Brands
Manufacturing
Distribution
Patient Care Initiatives
Improving Health Outcomes in Hypertension
Improving Health Outcomes in Diabetes
Improving Health Outcomes in Gynaecology and Pediatrics
Improving Health Outcomes in Pain management
Improving Health Outcomes in Neurology
Investors
Details of Business
Board of Directors
Policies
Shareholding Pattern
Corporate Announcements
Financials
Annual Reports
Financial Statement of Subsidiaries
Grievances Redressal
News
M&A And Alliances
Corporate Announcements
Investor-Analyst Meeting
Intimation of Analyst Institutional Investor Meetings for March 2019
Intimation of Analyst Institutional Investor Meetings for February 2019
Intimation of Analyst Institutional Investor Meetings for January 2019
Intimation of Analyst Institutional Investor Meetings for December 2018
Intimation of Analyst Institutional Investor Meetings for November 2018
Intimation of Analyst Institutional Investor Meetings for October 2018
Intimation of Analyst Institutional Investor Meetings for September 2018
Intimation of Analyst Institutional Investor Meetings for August 2018
Intimation of Analyst Institutional Investor Meetings for July 2018
Intimation of Analyst Institutional Investor Meetings for June 2018
Intimation of Analyst Institutional Investor Meetings for April 2018
Intimation of Analyst Institutional Investor Meetings for March 2018
Intimation of Analyst Institutional Investor Meetings for February 2018
Intimation of Analyst Institutional Investor Meetings for February 13,2018
Intimation of Analyst Institutional Investor Meetings for January 2018
Intimation of Analyst Institutional Investor Meetings for December 2017
Intimation of Analysts & Institutional Investor call – November 20, 2017
Intimation of Analysts & Institutional Investor call October 2017
Intimation of Analysts & Institutional Investor call September 2017
Record of analysts Institutional Investor Meetings for October 2017
Record of analysts Institutional Investor Meeting for September 2017
Notice to Shareholders
Newspaper Notice for AGM, E-voting and Book Closure – 2018
AGM Notice 2018
AGM Notice 2017
Intimation about mandatory dematerialization for transfer of securities
Newspaper Notice for AGM, E-voting and Book Closure – 2017
Notices of Board Meeting
Newspaper Notice of Board Meeting – May 21 2019
Notice of Board Meeting – May 21, 2019
Notice of Board Meeting – January 29, 2019
Newspaper Notice of Board Meeting – January 29, 2019
Newspaper Notice of Board Meeting – November 3, 2018
Notice of Board Meeting – November 3, 2018
Newspaper Notice of Board Meeting – August 9, 2018
Notice of Board Meeting – August 9, 2018
Notice of Board Meeting – May 25, 2018
Newspaper Notice of Board Meeting – May 25, 2018
Newspaper Notice of Board Meeting – February 12, 2018
Notice of Board Meeting – February 12, 2018
Notice of Board Meeting – November 18, 2017
Newspaper Notice of Board Meeting – November 18, 2017
Notice of Board Meeting – August 17, 2017
Newspaper Adervtisement for Board meetings to be hold on 17.08.2017
Miscellaneous
Consolidation Of ShareHolding In The Subsidiary Kinedex Healthcare Private Limited
Credit Rating Obtained
PROCEEDINGS OF 12th AGM
PROCEEDINGS OF 11th AGM
Voting results along with Scrutinizer Report for 12th AGM of the Company
Details of the information required under section 160 and 168_of the Companies Act 2013 & under Regulation 30(8) of SEBI_(LODR) 2015
Update on ‘Strides Shasun’s divestment of India brand business to Eris Lifesciences’
Procedure and fees for requests received under section 20 of the Companies Act, 2013
Material Announcement
Acquisition of India brand business of Strides Shasun Limited
Press Release Strides Shasun divests India brand business to Eris Lifesciences
Acquisition of UTH HEALTHCARE LIMITED
Voting results along with Scrutinizer Report for 11th AGM of the Company
Notification to Exchange 16.08.2017
